Chlorpromazine as a discriminative stimulus in rats: Generalization to typical and atypical antipsychotics

Drug Development Research

Volumn 48, Issue 1, 1999, Pages 38-44

  Porter, Joseph H ^a   Covington III, Herbert E ^a   Varvel, Stephen A ^a   Vann, Robert E ^a   Warren, Tracy A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Chlorpromazine; Clozapine; Drug discrimination; Haloperidol; Olanzapine; R aclopride; Schizophrenia; Thioridazine

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; OLANZAPINE; RACLOPRIDE; THIORIDAZINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SCHIZOPHRENIA;

EID: 0032709281     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199909)48:1<38::AID-DDR5>3.0.CO;2-C     Document Type: Article

References (40)

1. Arnt J, Skarsfeldt T. 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
2. Barry H III, Steenberg ML, Manian AA, Buckley JE 1974. Effects of chlorpromazine and three metabolites on behavioral responses in rats. Psychopharmacology (Berlin) 34:351-360.
3. Browne RG, Koe BK. 1982. Clozapine and agents with similar behavioral and biochemical properties. In: Colpaert FC, Slangen JL, editors. Drug discrimination: applications in CMS pharmacology. Amsterdam: Elsevier Biomedical Press. p 241-254.
4. Carey GJ, Bergman J. 1997. Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology 132:261-269.
5. Cole JO, Gardos G. 1976. Psychopharmacology update. J McLean Hosp 1:155-165.
6. Colpaert FC, Niemegeers CJE, Janssen PAJ. 1976. Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia (Berlin) 46169-46177.
7. Extance K, Goudie A. 1981. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73:363-371.
8. Franklin SR, Tang AH. 1994. Discriminative stimulus effects of clozapine in rats (Abstract). Behav Pharmacol 5:113-114.
9. Goas JA, Boston JE Jr. 1978. Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8:235-241.
10. Goldstein A. 1964. Biostatistics: an introductory text. New York: MacMillan.
11. Goudie AJ, Taylor A. 1998. Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392-400.
12. Goudie AJ, Smith JA, Taylor A, Taylor MAI, Tricklebank MD. 1998. Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behav Pharmacol 9:699-710.
13. Harris RT, Balster RL. 1971. An analysis of the function of drugs in the stimulus control of operant behavior, In: Thompson T, Pickens R, editors. Stimulus properties of drugs. New York: Meredith. p 111-132.
14. Hoenicke EM, Vanecek SA, Woods JH. 1992. The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine-lc and 5-hydroxytryptamine-2 receptors. J Pharmacol Exp Ther 263:276-284.
15. Jackson DM, Ryan C, Evenden J, Mohell N. 1994. Preclinical findings with new antipsychotic agents: what makes them atypical? Acta Psychiat Scand 89:41-48.
16. Kelley BM, Porter JH. 1997. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacol Biochem Behav 57:707-719.
17. 3H-raclopride: a potent substituted benzamide with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34(13):2251-2259.
18. Lewander T, Uppfeldt G, Kohler C, Ericson H, von Bahr C, Movin-Osswald G. 1992. Remoxipride and raclopride: pharmacological background and clinical outcome. In: Meltzer HY, editor. Novel antipsychotic drugs. New York: Raven Press. p 67-78.
19. McElroy JE Stimmel JJ, O'Donnell JM. 1989. Discriminative stimulus properties of haloperidol. Drug Dev Res 18:47-55.
20. Meert TE 1991. Application of drug discrimination with drugs of abuse to develop new therapeutic agents, In: Glennon RA, Jarbe TUC, Frankenheim J, editors. Drug discrimination: application to drug abuse research. Rockville, MD: NIDA (Research Monograph 116). p 307-323.
21. Meltzer HY, Fang VS. 1976. The effects of neuroleptics on serum prolactin levels in schizophrenic patients. Arch Gen Psychiatry 33:279-286.
22. i values. J Pharmacol Exp Ther 251:238-246.
23. Moore NC, Gershon S. 1989. Which atypical antipsychotics are identified by screening tests? Clin Neuropharmacol 12:167-184.
24. Moore NA, Tye NC, Axton MS, Risius FC. 1992. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551.
25. Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC. 1993. The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2:281-293.
26. Nielsen EB. 1988. Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology 94:115-118.
27. Ortmann R, Meisburger JG, Bischoff S, Hauser K, Bittiger H, Waldmeier PC. 1986. The clozapine cue in rats as tools for the characterization of neuroleptics (Abstract). Psychopharmacology 89:547.
28. Overton DA. 1966. State dependent learning produced by depressant and atropine-like drugs. Psychopharmacology (Berlin) 10:6-31.
29. Overton DA. 1984. State dependent learning and drug discrimination. In: Iverson LL, Iverson, SD, Snyder, SH, editors. Handbook of pharmacology, vol 18. New York: Plenum. p 59-127.
30. 2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats. Drug Dev Res 46:139-147.
31. Richelson E, Nelson A. 1984. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103:197-204.
32. Sachar EJ, Gruen PH, Karasu TB, Altman N, Frantz AG. 1975. Thioridazine stimulates prolactin secretion in man. Arch Gen Psychiatry 32:885-886.
33. 4 receptors. Neuropsychopharmacology 16:93-110.
34. Stewart J. 1962. Differential responses based on the physiological consequences of pharmacological agents. Psychopharmacologia 3:132-138.
35. Tamminga CA. 1983. Atypical neuroleptics and novel antipsychotic drugs. In: Coyle JT, Enna JS, editors. Neuroleptics: neurochemical, behavioral, and chemical perspectives. New York: Raven Press. p 281-295.
36. Villanueva HF, Arezo S, Rosecrans JA, Porter JH. 1990. Discriminative stimulus properties of clozapine. Soc Neurosci Abstracts 16:248.
37. Wiley JL, Porter JH. 1992. Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43:961-965.
38. Wiley JL, Porter JH. 1993. Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol. Bull Psychonomic Soc 31:94-96.
39. Wiley JL, Compton AD, Porter JH. 1993. Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 45:263-267.
40. Winter JC, Rabin RA. 1989. Yohimbine and serotonergic agonists: stimulus properties and receptor binding. In: Lal H, Fielding S, editors. Drugs as interoceptive stimuli. Drug Dev Res 16: 327-333.